Kerasal Nail Reaches #2 Brand Position, with Retail Sales Growth of over 450%

Report this content

Kerasal Nail is the fastest growing product in the fungal nail category in in pharmacies and Walmart stores in the United States.

Retail sales of Kerasal Nail continue to grow in pharmacies and Walmart stores in the United States . According to data reported by Symphony IRI, retail sales of Kerasal Nail at Multi-Outlet stores (Food, Drug and Mass retail stores including Walmart) grew by over 450% for the 52 weeks ending April 21, 2013.  For the same period Kerasal Nail was the #2 selling brand in the fungal nail category, with retail sales more than 25% higher than those of the next closest competitor.

About Moberg Pharma
Moberg Pharma AB (publ) is a rapidly growing Swedish pharmaceutical company with direct sales through its own sales organization in the US and sales through distributors in more than 35 countries. The company’s product portfolio includes topical products for the treatment of skin disorders and pain under the brands Kerasal®, Jointflex®, Kerasal Nail® and Kaprolac®. Kerasal Nail® (Nalox™ in many markets) is the leading product for the treatment of nail disorders in the Nordic market. The portfolio is developed further through acquisitions and in-licensing of products as well as product development with focus on innovative drug delivery based on proven compounds. Moberg Pharma has offices in Stockholm and New Jersey and the company’s share (OMX: MOB) is listed on the Small Cap list of the NASDAQ OMX Nordic Exchange Stockholm. For further information, please visit: